© Shutterstock, PopTika

Futurology in Cologne

The future is bright!

Future proofed. Over the next few years, Cologne intends to further expand its position as a leading science city. By 2030, it will have invested more than 100 million euros in the Biocampus Cologne (BCC) project. The BCC is already one of the largest technology parks in Germany and, on some 25 hectares, offers an ideal environment for innovative technology companies.
Monrol, a Turkish biotech and world leader in nuclear medicine, is relocating to Cologne's Immendorf industrial park where it is establishing a center of excellence for radiopharmaceutical production. The new site, at which more than 100 staff will develop cancer therapy products, is being funded to the tune of 30 million euros.

As a science center, Cologne is being transformed into a showcase region. Home to the CoRe-Net research and development network for improving medical and social care in Germany, the Cathedral City is one of the few centers selected by the German Federal Ministry of Education and Research (BMBF) for this unprecedented level of structural funding.

Cologne’s dynamism and collaborative spirit is also evident when it comes to teaching and science. In partnership with HHU Düsseldorf, TH Köln university is developing a 3D printing process for patient-specific drugs. The novel process helps to improve the efficacy of the drugs and minimize their side effects

„Eine Runde mit …“

The science podcast of the German Sport University Cologne

The German Sport University (DSHS) Cologne's new German-language science podcast is dedicated to exploring research issues. Listeners get to know the DSHS research staff through face-to-face interviews and learn about their current sports science research activities.


New research networks at the University of Cologne

CANcer TARgeting

The University of Cologne has also successfully established new research networks.
Using the new oncology network CANTAR (CANcer TARgeting), chemistry, biology and medical researchers are collaborating in a way that is unique in Europe. The group's focus is on the discovery and development of substances that specifically target cancer cells and spare healthy tissue.



The iBehave research network, in which the University of Cologne participates as a co-applicant, brings together world-class scientists who conduct interdisciplinary research into survival-related behaviors and their underlying neural networks and mechanisms. Through iBehave, the scientists hope to have a lasting international impact on neuroscience, computer science and medicine.